# NanoMosaic

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nanomosaic

- Industry: Biotechnology
- Headquarters: Woburn, US
- Website: www.nanomosaicllc.com
- Total disclosed funding: $41M
- Latest round: Series A (Dec 6, 2021)
- Investors on record: 5

## About

Based in Massachusetts, US, and founded in 2018 by John Boyce, and Qimin Quan, NanoMosaic LLC develops MosaicNeedle™, a device that performs early illness detection, prognostic monitoring, and biomarker identification. In December 2021, NanoMosaic LLC raised USD 40.75 million in a Series A funding led by RA Capital, with participation from Insight Partners, Pura Vida Investments, and Time BioVentures, and TigerGene LLC. As of December 2021, NanoMosaic LLC. has raised a total of USD 40.75 million in funding and co-founder John Boyce is the interim President and CEO of the company.

NanoMosaic LLC provides MosaicNeedle™, a nanoneedle detection for proteomics and multi-omics applications. Nanoneedles’ features include single-molecule sensitivity, absolute quantitation, label-free detection, small sample size, ultra-high throughput, and high-multiplex for protein and nucleic acid interrogation. In addition, the company is also developing Tessie, early disease detection and prognosis platform to enable rapid end-user customized chips (DIY) with antibodies and/or aptamers, eliminating sample prep reactions when working from plasma, and others.

NanoMosaic LLC plans to use its proceeds from a Series A funding to build its commercial infrastructure, further its application development efforts, and advance its collaborative diagnostic development programs.

## Funding rounds

- Series A, Dec 6, 2021, $41M — Insight Partners, Pura Vida Investments, RA Capital Management, Time BioVentures, TigerGene LLC

## Investors

- Insight Partners (https://capitalatlas.ai/funds/insight-partners) — Series A
- Pura Vida Investments (https://capitalatlas.ai/funds/pura-vida-investments) — Series A
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series A
- Time BioVentures (https://capitalatlas.ai/funds/time-bioventures) — Series A
- TigerGene LLC — Series A